Projected Price to Earnings: Baird Medical (BDMD)

BDMD (Baird Medical Investment) - company brandmark

Baird Medical Investment develops advanced microwave ablation systems for the bloodless removal of neoplasms. The automation of these devices minimizes physician error during energy delivery. Patent protection in Asia and the technical complexity of the equipment create a robust market barrier. The company's forward P/E ratio reflects valuation dynamics, with the current level sitting around 0.00.

Baird Medical Investment - BDMD Market Cap to Future Earnings Ratio (period 10/03/2024 - 11/17/2026)

Metric breakdowns and analytics for Baird Medical (BDMD)

- company stock exchange capitalization indicators:
Fundamental valuation:BDMD Baird Medical Investment
Brand item of bairdmed.com

The forward P/E ratio relates the current market value of the business to projected net income, determining the extent to which an asset is overvalued relative to its cash flow generation potential. By analyzing the consensus forward P/E of Baird Medical Investment (BDMD), investors assess the sustainability of demand for minimally invasive ablation technologies in China, where the efficacy of neoplasm treatment directly determines the investment attractiveness and the margin of safety for BDMD shares.

Competitors of Baird Medical Investment

Forward P/E Multiple DXCM|Forward P/E Multiple Penumbra, Inc. (PEN)|Novanta Photonics - Projected Price to Earnings|Market Cap to Future Earnings Ratio HAE (Haemonetics Corporation)|INSP: Projected Price to Earnings|PROCEPT BioRobotics Corporation - Market Cap to Future Earnings Ratio|CNMD: Forward P/E Multiple|PLSE - Market Cap to Projected Earnings|INMD (inmodemd.com) - Forward P/E Multiple|PMI: Future Price to Earnings Multiple|Projected Price to Earnings SRDX (Surmodics)|SENS (Senseonics Corp) - Future Price to Earnings Multiple|Future Price to Earnings NeuroPace Medical NPCE|TCMD - Projected Price to Earnings|SANUWAVE Health - Forward P/E Multiple|Market Cap to Projected Earnings Outset Medical, Inc. OM|ELMD: Forward P/E Multiple|Price to Future Earnings Ratio LNSR|RCEL (AVITA Medical Inc) - Forward P/E Multiple|Profound Medical Corp. (PROF) - Market Cap to Projected Earnings|Forward P/E Multiple EDAP|Projected Price to Earnings Apyx Medical Corporation APYX|Forward P/E Multiple ICCM (IceCure Medical Ltd.)|Forward P/E Multiple Pulmonx Corporation LUNG|TELA - Future Price to Earnings|CTSO: Future Price to Earnings|SRTS (Sensus Healthcare, Inc.) - Projected Price to Earnings|Zynex, Inc. - Future Price to Earnings Multiple|ECOR (electroCore Inc) - Forward P/E Multiple|Projected Price to Earnings Ratio vicarioussurgical.com RBOT|Future Price to Earnings Inspira Technologies (IINN)|Forward P/E Multiple SeaStar Medical Holding Corp (ICU)|IRIDEX Corp - Projected Price to Earnings|Forward P/E Multiple Intelligent Bio INBS|Beyond Air Inc - Forward P/E Multiple|Market Cap to Projected Earnings Profusa Inc. PFSA|STRATA Skin Sciences, Inc. (SSKN) - Future Price to Earnings|Price to Expected Earnings Ratio GCTK (GlucoTrack Inc.)|Future Price to Earnings nanovibronix.com|Projected Price to Earnings Venus Concept Inc. (VERO)|Forward P/E Multiple NUWE|AEMD - Projected Price to Earnings Ratio|Future Price to Earnings asensus.com ASXC|AVGR: Price to Future Earnings Ratio|BSGM: Projected Price to Earnings|Cutera, Inc. - Market Cap to Future Earnings Ratio|Know Labs Corp (KNW) - Future Price to Earnings|NARI - Market Cap to Projected Earnings|NVRO (nevro.com) - Forward P/E Multiple|Projected Price to Earnings Ratio reshapelifesciences.com RSLS|Future Price to Earnings Silk Road Medical, Inc (SILK)